Skip to main content

Table 5 Prognostic value of Bcl-2 expression estimated by multivariate analysis in 76 triple-negative basal-like FMCs

From: Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study

  Categories p HR 95%-CI
Overall survival
 Bcl-2 expression Bcl-2+ versus Bcl-2– 0.047 0.53 0.28–0.99
 WHO stage Stages I–II versus III–IV 0.004 2.13 1.28–3.54
Cancer-specific survival
 Bcl-2 expression Bcl-2+ versus Bcl-2– 0.047 0.45 0.21–0.99
 Pathologic nodal stage pNX versus pN0 0.158 2.22 0.74–6.72
pN+ versus pN0 0.004 4.66 1.63–13.34